220 related articles for article (PubMed ID: 36999187)
21. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.
Salmina AB; Kharitonova EV; Gorina YV; Teplyashina EA; Malinovskaya NA; Khilazheva ED; Mosyagina AI; Morgun AV; Shuvaev AN; Salmin VV; Lopatina OL; Komleva YK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925080
[TBL] [Abstract][Full Text] [Related]
22. Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.
Ronaldson PT; Davis TP
J Cereb Blood Flow Metab; 2020 Dec; 40(1_suppl):S6-S24. PubMed ID: 32928017
[TBL] [Abstract][Full Text] [Related]
23. Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System Disorders.
Thurgur H; Pinteaux E
Neuroscience; 2019 May; 405():55-67. PubMed ID: 31007172
[TBL] [Abstract][Full Text] [Related]
24. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
Harati R; Hammad S; Tlili A; Mahfood M; Mabondzo A; Hamoudi R
PLoS One; 2022; 17(1):e0262152. PubMed ID: 35025943
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
26. The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?
Diao X; Han H; Li B; Guo Z; Fu J; Wu W
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504937
[TBL] [Abstract][Full Text] [Related]
27. Neurovascular Unit Dysfunction and Neurodegenerative Disorders.
Yu X; Ji C; Shao A
Front Neurosci; 2020; 14():334. PubMed ID: 32410936
[TBL] [Abstract][Full Text] [Related]
28. Blood-Brain Barrier Breakdown in Stress and Neurodegeneration: Biochemical Mechanisms and New Models for Translational Research.
Salmina AB; Komleva YK; Malinovskaya NA; Morgun AV; Teplyashina EA; Lopatina OL; Gorina YV; Kharitonova EV; Khilazheva ED; Shuvaev AN
Biochemistry (Mosc); 2021 Jun; 86(6):746-760. PubMed ID: 34225598
[TBL] [Abstract][Full Text] [Related]
29. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the blood-brain barrier in Parkinson's disease: curse or route to a cure?
Lee H; Pienaar IS
Front Biosci (Landmark Ed); 2014 Jan; 19(2):272-80. PubMed ID: 24389183
[TBL] [Abstract][Full Text] [Related]
31. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
[TBL] [Abstract][Full Text] [Related]
32. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
33. Neurovascular unit disruption and blood-brain barrier leakage in MCT8 deficiency.
Guillén-Yunta M; Valcárcel-Hernández V; García-Aldea Á; Soria G; García-Verdugo JM; Montero-Pedrazuela A; Guadaño-Ferraz A
Fluids Barriers CNS; 2023 Nov; 20(1):79. PubMed ID: 37924081
[TBL] [Abstract][Full Text] [Related]
34. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease.
Lan G; Wang P; Chan RB; Liu Z; Yu Z; Liu X; Yang Y; Zhang J
Glia; 2022 Feb; 70(2):337-353. PubMed ID: 34713920
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
Abbott NJ
J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
[TBL] [Abstract][Full Text] [Related]
36. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
Yan L; Moriarty RA; Stroka KM
Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
[TBL] [Abstract][Full Text] [Related]
37. The Role of Neurovascular System in Neurodegenerative Diseases.
Ahmad A; Patel V; Xiao J; Khan MM
Mol Neurobiol; 2020 Nov; 57(11):4373-4393. PubMed ID: 32725516
[TBL] [Abstract][Full Text] [Related]
38. Blood-brain barrier dysfunction and recovery after ischemic stroke.
Jiang X; Andjelkovic AV; Zhu L; Yang T; Bennett MVL; Chen J; Keep RF; Shi Y
Prog Neurobiol; 2018; 163-164():144-171. PubMed ID: 28987927
[TBL] [Abstract][Full Text] [Related]
39. The role of the blood-brain barrier in hypertension.
Setiadi A; Korim WS; Elsaafien K; Yao ST
Exp Physiol; 2018 Mar; 103(3):337-342. PubMed ID: 28986948
[TBL] [Abstract][Full Text] [Related]
40. Stroke-induced damage on the blood-brain barrier.
Xue S; Zhou X; Yang ZH; Si XK; Sun X
Front Neurol; 2023; 14():1248970. PubMed ID: 37840921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
